Investment analysts at StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a research note issued on Friday. The brokerage set a “sell” rating on the stock.
Separately, HC Wainwright reaffirmed a “buy” rating and issued a $35.00 price objective on shares of SenesTech in a report on Tuesday, May 14th.
Check Out Our Latest Stock Analysis on SenesTech
SenesTech Trading Down 3.4 %
SenesTech (NASDAQ:SNES – Get Free Report) last released its quarterly earnings data on Thursday, August 8th. The company reported ($3.08) EPS for the quarter, topping the consensus estimate of ($3.20) by $0.12. The business had revenue of $0.46 million for the quarter, compared to analyst estimates of $0.49 million. SenesTech had a negative return on equity of 168.64% and a negative net margin of 464.09%. During the same quarter in the prior year, the firm posted ($84.03) EPS. As a group, equities analysts predict that SenesTech will post -11 EPS for the current year.
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Stories
- Five stocks we like better than SenesTech
- The How And Why of Investing in Oil Stocks
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- How to Invest in the Best Canadian StocksĀ
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- Learn Technical Analysis Skills to Master the Stock Market
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.